Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $575,432 - $752,615
-6,599 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $10,360 - $13,693
110 Added 1.7%
6,599 $731,000
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $36,947 - $42,972
309 Added 5.0%
6,489 $834,000
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $51,964 - $67,758
476 Added 8.35%
6,180 $830,000
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $82,579 - $95,212
-823 Reduced 12.61%
5,704 $623,000
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $662,555 - $817,637
6,527 New
6,527 $676,000
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $279,711 - $343,157
-3,257 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$72.74 - $92.5 $145,916 - $185,555
-2,006 Reduced 38.12%
3,257 $277,000
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $289,224 - $476,057
-6,023 Reduced 53.37%
5,263 $379,000
Q1 2020

May 14, 2020

SELL
$36.95 - $62.95 $24,128 - $41,106
-653 Reduced 5.47%
11,286 $569,000
Q4 2019

Feb 14, 2020

SELL
$47.06 - $56.64 $140,897 - $169,580
-2,994 Reduced 20.05%
11,939 $676,000
Q3 2019

Nov 14, 2019

BUY
$47.45 - $58.05 $346,242 - $423,590
7,297 Added 95.56%
14,933 $709,000
Q2 2019

Aug 14, 2019

SELL
$39.26 - $54.21 $1.14 Million - $1.57 Million
-29,017 Reduced 79.17%
7,636 $411,000
Q1 2019

May 07, 2019

SELL
$29.84 - $43.92 $613,689 - $903,258
-20,566 Reduced 35.94%
36,653 $1.49 Million
Q4 2018

Feb 01, 2019

SELL
$29.95 - $46.34 $356,105 - $550,982
-11,890 Reduced 17.2%
57,219 $1.78 Million
Q3 2018

Nov 14, 2018

BUY
$40.12 - $45.55 $1.06 Million - $1.2 Million
26,302 Added 61.44%
69,109 $3.15 Million
Q2 2018

Aug 14, 2018

BUY
$38.72 - $42.52 $1.66 Million - $1.82 Million
42,807 New
42,807 $2.05 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.